What Are the Latest Advancements in Infusion Care?

The infusion care market is being redrawn. New drug therapies, shifting care settings, and rapidly evolving technology are forcing health systems to make decisions today that will define their competitive position for years to come. Here’s what healthcare leaders need to know.

Why Infusion Care is a Strategic Priority

Demand for infusion therapy is rising on multiple fronts. Chronic disease prevalence is driving higher therapy volumes, specialty infusion is growing as the drug pipeline expands into conditions that previously had non-specific, limited, or no treatment options, and home infusion is gaining ground as a cost-effective, patient-preferred alternative to traditional settings. Meanwhile, the medical device market continues to advance the technology supporting all of it.

But the strategic pressure runs deeper than volume or device upgrades. Laura Stokes, VP of Pharmacy Services at Visante, points to a fundamental shift in the drug pipeline itself.

“Home infusion is historically an old industry,” she explains. “It was founded on mostly acute-type therapy. What’s happened is the drug pipeline has shifted in a way that there are far more infusible specialty drugs on the market to treat diseases we haven’t historically had therapies for.”

That shift has real consequences. The increasing complexity of specialty therapies has complicated both care delivery and the path to payment, forcing infusion programs to take a hard look at whether their pharmacy processes are built for what the market now demands.

Technology Integration Challenges for Health Systems

Health systems are often early adopters of technology, but integrating it into infusion workflows has proven more complicated than anticipated. Most existing systems simply weren’t built with infusion in mind, whether that’s home infusion or ambulatory infusion suites.

A common example: health systems want to leverage their EHR to give providers real-time visibility into referral status and patient updates. The problem is that many infusion pharmacies operate on separate dispensing and billing platforms that don’t integrate cleanly with the health system’s primary system of record — creating a need to double-document across systems. That risks transcription errors, fragmented data, and compliance exposure.

What’s emerging is a scrappy, retrofit approach: health systems adapting the tools they already have to fill gaps that purpose-built solutions haven’t addressed yet. It’s imperfect, but it signals where the industry is headed.

What Advancements & Technology are Moving the Needle in Infusion?

The infusion landscape is being reshaped at multiple points in the care continuum, from upstream authorization processes to downstream analytics and drug delivery. Understanding where technology is making its mark, and where gaps remain, is essential for health systems planning their next move.

1. AI-Driven Automation in Medication Access

One of the most significant shifts in infusion care is happening before a single drug is prepared or administered. AI is increasingly being applied to the medication access process, including benefit investigation, prior authorization, and payer contract management.

“Before AI, you would have sat on the phone for two hours to get the answer to one question. AI helps automate those functions,” says Stokes. “Now, you can service more patients, grow your business, and do it more expeditiously.”

The impact extends beyond convenience. Authorization bottlenecks cap the number of patients an infusion program can serve on any given day. Automating those workflows directly expands capacity while standardizing the process in ways that manual handling can’t. Fewer handoffs mean fewer opportunities for human error, and a consistent, repeatable approach holds up whether a program is managing ten patients or a hundred. That has real financial implications for health systems managing growing specialty therapy volumes.

2. Smart Infusion Pumps & Interoperability

Modern infusion technology is increasingly defined by smart pumps equipped with dose error reduction systems and interoperability with electronic health records (EHR). These advancements enable:

• Real-time clinical decision support
• Automated documentation
• Improved medication safety
• More consistent and controlled care delivery

3. Expansion of Home Infusion Therapy

Home infusion therapy continues to gain momentum as care shifts beyond traditional settings. Patient preference for convenience, lower overall cost of care, and advances in portable drug delivery devices are all accelerating the shift. Health systems that invest in home infusion models can expand access, reduce inpatient utilization, and improve patient satisfaction.

“Nobody is going to care about a patient in as much depth, across their entire continuum of care, the way a health system does,” Stokes says. “Health systems are reimbursed based on readmission rates and patient outcomes. They really care about what happens when a patient goes home. In the private world, a company might care that a patient was readmitted, but it doesn’t affect their bottom line.”

4. Connected Devices & Infusion Analytics

Connected infusion systems are enabling greater visibility into performance and outcomes. With infusion analytics, organizations can:

• Monitor utilization in real time
• Identify workflow inefficiencies
• Track outcomes across care settings

This supports more informed, data-driven decision-making.

5. Precision Drug Delivery for Specialty Therapies

As specialty infusion grows, precision drug delivery is becoming more critical. Advancements in this area support accurate dosing for complex therapies, safer administration of high-risk medications, and greater consistency in care. All of these factors become increasingly important as specialty infusion centers take on more complex cases.

6. Clean Room Infrastructure & Regulatory Risks

One area of infusion operations that often goes overlooked in strategic planning is clean room design. It carries more risk than most health system leaders realize. Unlike inpatient pharmacies, home infusion pharmacies are independently licensed. If a clean room goes down, there is no backup. For a patient who needs their total parenteral nutrition (TPN) that day, that’s a clinical emergency.

“Business continuity becomes a real question,” says Stokes. “One of the things I’m a strong proponent of is building dual clean rooms: two clean rooms, separate ductwork, separate HVAC, full separate mechanical. You can operate them at normal capacity day-to-day. But if you have an HVAC issue or a regulatory closure, you have the flexibility to move to the other room and keep serving your patients.”

Health system clean rooms have historically been evaluated as immediate-use environments, where medication is compounded and administered the same day. But home infusion pharmacies dispense medications for up to seven days, creating meaningfully higher contamination risk. The FDA is increasingly evaluating these facilities not as 503A spaces, but closer to 503B standards.

Companies that engage in longer beyond-use dating tend to have more thorough quality programs, more rigorous garbing and cleaning procedures, and more intensive environmental monitoring, standards that health systems haven’t historically been held to. As they expand into home infusion, that gap becomes a real and addressable risk.

What Do These Advancements Mean for Health Systems?

The convergence of technology, analytics, and evolving care models is creating both opportunity and complexity. Health systems that take a strategic approach can achieve:

• Improved patient outcomes through safer, more precise therapy delivery
• Greater operational efficiency through streamlined workflows and reduced manual processes
• Stronger financial performance by shifting care to lower-cost settings and optimizing infusion services

And according to Stokes, the financial case is even stronger for health systems with 340B eligibility.

“For eligible health systems, 340B can help support the long-term sustainability of infusion pharmacy programs. What I think is often overlooked is the broader value of keeping that care connected within the health system. Providers have better visibility, patients benefit from a more coordinated experience, and the organization is better positioned to reinvest in programs and services that support patient care,” Stokes adds.

How Can Health Systems Keep Pace with Infusion Innovation?

Technology alone is not enough. Success requires alignment across strategy, operations, and clinical care. Leading organizations are focusing on integrated infusion strategies across care settings, pharmacy-led transformation to manage specialty therapies, data-driven decision making, and cross-functional collaboration.

Building out a home infusion or ambulatory infusion service within a health system is nuanced. It involves nursing, credentialing, accreditation, billing, clean room design, technology infrastructure, and so much more.

That’s where Visante comes in. As more health systems look to expand their ambulatory infusion footprint and compete in an increasingly crowded market, the need for end-to-end expertise is clear.

“When we come to the table and say we provide this end-to-end service, the message resonates,” Stokes notes. “They know the vision, they understand the market, and it’s just a matter of connecting the dots.”

Infusion Care Is Evolving. Is Your Strategy?

Visante works alongside health systems as a true extension of their team, helping translate infusion advancements into strategies that deliver real, measurable impact. Ready to build an infusion strategy that keeps pace with the market? Connect with our team today.